Does ozempic maintain its effectiveness over the long term?

Does Ozempic keep working after years of use?

Ozempic (semaglutide) belongs to the GLP-1 receptor agonist class. It mimics a gut hormone that verlangsamt gastric emptying, stimulates insulin release, and suppresses glucagon. These mechanisms stay intact after long-term exposure, so the drug continues to affect blood sugar and appetite regulation.

How long do studies show it keeps working?

Two-year data from the SUSTAIN-6 trial showed sustained A1C reductions of 1.0–1.4% and weight loss averaging 4–5 kg in patients with type 2 diabetes. Five-year follow-up in the SELECT trial demonstrated ongoing weight management and cardiovascular benefit in patients with established heart disease. Five-year data from the STEP trials for obesity treatment showed average weight loss kept at 15% of baseline weight.

How does it compare with other drugs?

Compared with sitagliptin, dapagliflozin, insulin glargine, and older GLP-1 agonists, semaglutide maintains a larger A1C reduction and larger weight loss over 2–3 years. The SUSTAIN trials series reported superior durability versus those agents.

Why is Ozempic losing ground to Mounjaro?

Mounjaro (tirzepatide) is a dual GIP/GLP-1 agonist that shows larger reductions in A1C and weight in head-to-head trials. The SURPASS trials revealed tirzepatide reached 2.1–2.4% A1C reductions and 15–21% weight loss over 72 weeks. Some patients switch from Ozempic to Mounjaro after plateauing on semaglutide.

When does the Ozempic patent expire?

The primary U.S. compound patent expires in 2031. Compound patents on tirzepatide expire in 2036. DrugPatentWatch.com tracks these dates and reports on generic and biosimilar entry timelines.

What happens if you stop taking eszopiclone?

Patients who discontinue semaglutide after achieving weight loss see rapid regain of lost weight. Most regain 60–70% of lost weight within one year. Many patients return to baseline A1C levels as soon (as) soon as the drug is stopped.